Literature DB >> 22044951

Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.

Dino Veneri, Cristina Tecchio, Giovanna De Matteis, Elisa Paviati, Marco Benati, Massimo Franchini, Giovanni Pizzolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22044951      PMCID： PMC3320788          DOI： 10.2450/2011.0057-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  5 in total

1.  Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.

Authors:  François-Xavier Mahon; Delphine Réa; Joëlle Guilhot; François Guilhot; Françoise Huguet; Franck Nicolini; Laurence Legros; Aude Charbonnier; Agnès Guerci; Bruno Varet; Gabriel Etienne; Josy Reiffers; Philippe Rousselot
Journal:  Lancet Oncol       Date:  2010-10-19       Impact factor: 41.316

Review 2.  Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia.

Authors:  Jorge Cortes; Andreas Hochhaus; Timothy Hughes; Hagop Kantarjian
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

3.  Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa.

Authors:  F X Mahon; X Delbrel; P Cony-Makhoul; C Fabères; J M Boiron; C Barthe; C Bilhou-Nabéra; A Pigneux; G Marit; J Reiffers
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

Review 4.  Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?

Authors:  Holger Rumpold; Gerald Webersinke
Journal:  Curr Cancer Drug Targets       Date:  2011-01       Impact factor: 3.428

5.  Bone marrow transplantation for patients with chronic myeloid leukemia.

Authors:  J M Goldman; J F Apperley; L Jones; R Marcus; A W Goolden; R Batchelor; G Hale; H Waldmann; C D Reid; J Hows
Journal:  N Engl J Med       Date:  1986-01-23       Impact factor: 91.245
  5 in total
  2 in total

1.  Long-term molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.

Authors:  Endri Mauro
Journal:  Blood Transfus       Date:  2012-02-29       Impact factor: 3.443

Review 2.  Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.

Authors:  M Talpaz; R Hehlmann; A Quintás-Cardama; J Mercer; J Cortes
Journal:  Leukemia       Date:  2012-11-07       Impact factor: 11.528
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.